Innoviva
INVA
$15.98
Share price
0.00%
Change (1 day)
21.89%
Change (1 year)
Categories
P/S ratio for Innoviva (INVA)
P/S ratio as of May 2024 (TTM): 3.21
According to Innoviva's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.21413. At the end of 2023 the company had a P/S ratio of 3.31.
P/S ratio history for Innoviva from 2005 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 3.31 | 18.65% |
| 2022 | 2.79 | -8.78% |
| 2021 | 3.06 | -17.99% |
| 2020 | 3.73 | -32.12% |
| 2019 | 5.49 | -18.71% |
| 2018 | 6.76 | 1.54% |
| 2017 | 6.66 | -23.37% |
| 2016 | 8.69 | -61.26% |
| 2015 | 22.4 | -88.51% |
| 2014 | 195 | -76.79% |
| 2013 | 841 | 4661.18% |
| 2012 | 17.7 | -79.28% |
| 2011 | 85.2 | 2.48% |
| 2010 | 83.2 | 141.46% |
| 2009 | 34.4 | 22.12% |
| 2008 | 28.2 | -47.9% |
| 2007 | 54.1 | -42.93% |
| 2006 | 94.9 | 14.16% |
| 2005 | 83.1 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | 1.05 | -67.35% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | 92.5 | 2,777.87% | 🇺🇸 USA |